0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Allergen IgG Antibody Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-5P17170
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Allergen IgG Antibody Testing Market Research Report 2024
BUY CHAPTERS

Global Allergen IgG Antibody Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-5P17170
Report
November 2025
Pages:149
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Allergen IgG Antibody Testing Market

The global Allergen IgG Antibody Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Allergen IgG antibody detection is a detection method that detects the concentration of IgG antibodies caused by specific allergens (such as food, environment) in human blood.
From a downstream perspective, Child accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Allergen IgG Antibody Testing leading manufacturers including HOB Biotech Group, Zheda Dixun Biological Gene Engineering, Shenzhen Lvshiyuan Biotechnology, Phadia, Oumeng, BioMerieux, Mediwiss, Danaher, Omega Diagnostics Group, Biomerica, etc., dominate supply; the top five capture approximately % of global revenue, with HOB Biotech Group leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Allergen IgG Antibody Testing market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Allergen IgG Antibody Testing Market Report

Report Metric Details
Report Name Allergen IgG Antibody Testing Market
Segment by Type
  • Reagents
  • Equipment
Segment by Application
  • Child
  • Aldult
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company HOB Biotech Group, Zheda Dixun Biological Gene Engineering, Shenzhen Lvshiyuan Biotechnology, Phadia, Oumeng, BioMerieux, Mediwiss, Danaher, Omega Diagnostics Group, Biomerica
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Allergen IgG Antibody Testing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Allergen IgG Antibody Testing Market report?

Ans: The main players in the Allergen IgG Antibody Testing Market are HOB Biotech Group, Zheda Dixun Biological Gene Engineering, Shenzhen Lvshiyuan Biotechnology, Phadia, Oumeng, BioMerieux, Mediwiss, Danaher, Omega Diagnostics Group, Biomerica

What are the Application segmentation covered in the Allergen IgG Antibody Testing Market report?

Ans: The Applications covered in the Allergen IgG Antibody Testing Market report are Child, Aldult

What are the Type segmentation covered in the Allergen IgG Antibody Testing Market report?

Ans: The Types covered in the Allergen IgG Antibody Testing Market report are Reagents, Equipment

1 Study Coverage
1.1 Introduction to Allergen IgG Antibody Testing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Allergen IgG Antibody Testing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Reagents
1.2.3 Equipment
1.3 Market Segmentation by Application
1.3.1 Global Allergen IgG Antibody Testing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Child
1.3.3 Aldult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Allergen IgG Antibody Testing Revenue Estimates and Forecasts 2020-2031
2.2 Global Allergen IgG Antibody Testing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Allergen IgG Antibody Testing Sales Estimates and Forecasts 2020-2031
2.4 Global Allergen IgG Antibody Testing Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Allergen IgG Antibody Testing Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Allergen IgG Antibody Testing Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Reagents Market Size by Manufacturers
3.5.2 Equipment Market Size by Manufacturers
3.6 Global Allergen IgG Antibody Testing Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Allergen IgG Antibody Testing Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Allergen IgG Antibody Testing Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Allergen IgG Antibody Testing Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Allergen IgG Antibody Testing Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Allergen IgG Antibody Testing Sales and Revenue by Type (2020-2031)
6.4 North America Allergen IgG Antibody Testing Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Allergen IgG Antibody Testing Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Allergen IgG Antibody Testing Sales and Revenue by Type (2020-2031)
7.4 Europe Allergen IgG Antibody Testing Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Allergen IgG Antibody Testing Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Allergen IgG Antibody Testing Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Allergen IgG Antibody Testing Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Allergen IgG Antibody Testing Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Allergen IgG Antibody Testing Sales and Revenue by Type (2020-2031)
9.4 Central and South America Allergen IgG Antibody Testing Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Allergen IgG Antibody Testing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Allergen IgG Antibody Testing Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Allergen IgG Antibody Testing Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Allergen IgG Antibody Testing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 HOB Biotech Group
11.1.1 HOB Biotech Group Corporation Information
11.1.2 HOB Biotech Group Business Overview
11.1.3 HOB Biotech Group Allergen IgG Antibody Testing Product Models, Descriptions and Specifications
11.1.4 HOB Biotech Group Allergen IgG Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 HOB Biotech Group Allergen IgG Antibody Testing Sales by Product in 2024
11.1.6 HOB Biotech Group Allergen IgG Antibody Testing Sales by Application in 2024
11.1.7 HOB Biotech Group Allergen IgG Antibody Testing Sales by Geographic Area in 2024
11.1.8 HOB Biotech Group Allergen IgG Antibody Testing SWOT Analysis
11.1.9 HOB Biotech Group Recent Developments
11.2 Zheda Dixun Biological Gene Engineering
11.2.1 Zheda Dixun Biological Gene Engineering Corporation Information
11.2.2 Zheda Dixun Biological Gene Engineering Business Overview
11.2.3 Zheda Dixun Biological Gene Engineering Allergen IgG Antibody Testing Product Models, Descriptions and Specifications
11.2.4 Zheda Dixun Biological Gene Engineering Allergen IgG Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Zheda Dixun Biological Gene Engineering Allergen IgG Antibody Testing Sales by Product in 2024
11.2.6 Zheda Dixun Biological Gene Engineering Allergen IgG Antibody Testing Sales by Application in 2024
11.2.7 Zheda Dixun Biological Gene Engineering Allergen IgG Antibody Testing Sales by Geographic Area in 2024
11.2.8 Zheda Dixun Biological Gene Engineering Allergen IgG Antibody Testing SWOT Analysis
11.2.9 Zheda Dixun Biological Gene Engineering Recent Developments
11.3 Shenzhen Lvshiyuan Biotechnology
11.3.1 Shenzhen Lvshiyuan Biotechnology Corporation Information
11.3.2 Shenzhen Lvshiyuan Biotechnology Business Overview
11.3.3 Shenzhen Lvshiyuan Biotechnology Allergen IgG Antibody Testing Product Models, Descriptions and Specifications
11.3.4 Shenzhen Lvshiyuan Biotechnology Allergen IgG Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Shenzhen Lvshiyuan Biotechnology Allergen IgG Antibody Testing Sales by Product in 2024
11.3.6 Shenzhen Lvshiyuan Biotechnology Allergen IgG Antibody Testing Sales by Application in 2024
11.3.7 Shenzhen Lvshiyuan Biotechnology Allergen IgG Antibody Testing Sales by Geographic Area in 2024
11.3.8 Shenzhen Lvshiyuan Biotechnology Allergen IgG Antibody Testing SWOT Analysis
11.3.9 Shenzhen Lvshiyuan Biotechnology Recent Developments
11.4 Phadia
11.4.1 Phadia Corporation Information
11.4.2 Phadia Business Overview
11.4.3 Phadia Allergen IgG Antibody Testing Product Models, Descriptions and Specifications
11.4.4 Phadia Allergen IgG Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Phadia Allergen IgG Antibody Testing Sales by Product in 2024
11.4.6 Phadia Allergen IgG Antibody Testing Sales by Application in 2024
11.4.7 Phadia Allergen IgG Antibody Testing Sales by Geographic Area in 2024
11.4.8 Phadia Allergen IgG Antibody Testing SWOT Analysis
11.4.9 Phadia Recent Developments
11.5 Oumeng
11.5.1 Oumeng Corporation Information
11.5.2 Oumeng Business Overview
11.5.3 Oumeng Allergen IgG Antibody Testing Product Models, Descriptions and Specifications
11.5.4 Oumeng Allergen IgG Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Oumeng Allergen IgG Antibody Testing Sales by Product in 2024
11.5.6 Oumeng Allergen IgG Antibody Testing Sales by Application in 2024
11.5.7 Oumeng Allergen IgG Antibody Testing Sales by Geographic Area in 2024
11.5.8 Oumeng Allergen IgG Antibody Testing SWOT Analysis
11.5.9 Oumeng Recent Developments
11.6 BioMerieux
11.6.1 BioMerieux Corporation Information
11.6.2 BioMerieux Business Overview
11.6.3 BioMerieux Allergen IgG Antibody Testing Product Models, Descriptions and Specifications
11.6.4 BioMerieux Allergen IgG Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 BioMerieux Recent Developments
11.7 Mediwiss
11.7.1 Mediwiss Corporation Information
11.7.2 Mediwiss Business Overview
11.7.3 Mediwiss Allergen IgG Antibody Testing Product Models, Descriptions and Specifications
11.7.4 Mediwiss Allergen IgG Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Mediwiss Recent Developments
11.8 Danaher
11.8.1 Danaher Corporation Information
11.8.2 Danaher Business Overview
11.8.3 Danaher Allergen IgG Antibody Testing Product Models, Descriptions and Specifications
11.8.4 Danaher Allergen IgG Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Danaher Recent Developments
11.9 Omega Diagnostics Group
11.9.1 Omega Diagnostics Group Corporation Information
11.9.2 Omega Diagnostics Group Business Overview
11.9.3 Omega Diagnostics Group Allergen IgG Antibody Testing Product Models, Descriptions and Specifications
11.9.4 Omega Diagnostics Group Allergen IgG Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Omega Diagnostics Group Recent Developments
11.10 Biomerica
11.10.1 Biomerica Corporation Information
11.10.2 Biomerica Business Overview
11.10.3 Biomerica Allergen IgG Antibody Testing Product Models, Descriptions and Specifications
11.10.4 Biomerica Allergen IgG Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Biomerica Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Allergen IgG Antibody Testing Industry Chain
12.2 Allergen IgG Antibody Testing Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Allergen IgG Antibody Testing Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Allergen IgG Antibody Testing Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Allergen IgG Antibody Testing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Allergen IgG Antibody Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Allergen IgG Antibody Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Allergen IgG Antibody Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Allergen IgG Antibody Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Allergen IgG Antibody Testing Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Allergen IgG Antibody Testing Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Allergen IgG Antibody Testing Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Allergen IgG Antibody Testing Sales by Region (2020-2025) & (K Units)
 Table 8. Global Allergen IgG Antibody Testing Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Allergen IgG Antibody Testing Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Allergen IgG Antibody Testing Sales Share by Manufacturers (2020-2025)
 Table 12. Global Allergen IgG Antibody Testing Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Allergen IgG Antibody Testing Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Allergen IgG Antibody Testing by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergen IgG Antibody Testing as of 2024)
 Table 16. Global Allergen IgG Antibody Testing Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Allergen IgG Antibody Testing Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Allergen IgG Antibody Testing Manufacturing Base and Headquarters
 Table 19. Global Allergen IgG Antibody Testing Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Allergen IgG Antibody Testing Sales by Type (2020-2025) & (K Units)
 Table 23. Global Allergen IgG Antibody Testing Sales by Type (2026-2031) & (K Units)
 Table 24. Global Allergen IgG Antibody Testing Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Allergen IgG Antibody Testing Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Allergen IgG Antibody Testing ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Allergen IgG Antibody Testing Sales by Application (2020-2025) & (K Units)
 Table 29. Global Allergen IgG Antibody Testing Sales by Application (2026-2031) & (K Units)
 Table 30. Allergen IgG Antibody Testing High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Allergen IgG Antibody Testing Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Allergen IgG Antibody Testing Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Allergen IgG Antibody Testing ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Allergen IgG Antibody Testing Growth Accelerators and Market Barriers
 Table 37. North America Allergen IgG Antibody Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Allergen IgG Antibody Testing Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Allergen IgG Antibody Testing Growth Accelerators and Market Barriers
 Table 40. Europe Allergen IgG Antibody Testing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Allergen IgG Antibody Testing Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Allergen IgG Antibody Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Allergen IgG Antibody Testing Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Allergen IgG Antibody Testing Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Allergen IgG Antibody Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Allergen IgG Antibody Testing Investment Opportunities and Key Challenges
 Table 47. Central and South America Allergen IgG Antibody Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Allergen IgG Antibody Testing Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Allergen IgG Antibody Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. HOB Biotech Group Corporation Information
 Table 51. HOB Biotech Group Description and Major Businesses
 Table 52. HOB Biotech Group Product Models, Descriptions and Specifications
 Table 53. HOB Biotech Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. HOB Biotech Group Sales Value Proportion by Product in 2024
 Table 55. HOB Biotech Group Sales Value Proportion by Application in 2024
 Table 56. HOB Biotech Group Sales Value Proportion by Geographic Area in 2024
 Table 57. HOB Biotech Group Allergen IgG Antibody Testing SWOT Analysis
 Table 58. HOB Biotech Group Recent Developments
 Table 59. Zheda Dixun Biological Gene Engineering Corporation Information
 Table 60. Zheda Dixun Biological Gene Engineering Description and Major Businesses
 Table 61. Zheda Dixun Biological Gene Engineering Product Models, Descriptions and Specifications
 Table 62. Zheda Dixun Biological Gene Engineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Zheda Dixun Biological Gene Engineering Sales Value Proportion by Product in 2024
 Table 64. Zheda Dixun Biological Gene Engineering Sales Value Proportion by Application in 2024
 Table 65. Zheda Dixun Biological Gene Engineering Sales Value Proportion by Geographic Area in 2024
 Table 66. Zheda Dixun Biological Gene Engineering Allergen IgG Antibody Testing SWOT Analysis
 Table 67. Zheda Dixun Biological Gene Engineering Recent Developments
 Table 68. Shenzhen Lvshiyuan Biotechnology Corporation Information
 Table 69. Shenzhen Lvshiyuan Biotechnology Description and Major Businesses
 Table 70. Shenzhen Lvshiyuan Biotechnology Product Models, Descriptions and Specifications
 Table 71. Shenzhen Lvshiyuan Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Shenzhen Lvshiyuan Biotechnology Sales Value Proportion by Product in 2024
 Table 73. Shenzhen Lvshiyuan Biotechnology Sales Value Proportion by Application in 2024
 Table 74. Shenzhen Lvshiyuan Biotechnology Sales Value Proportion by Geographic Area in 2024
 Table 75. Shenzhen Lvshiyuan Biotechnology Allergen IgG Antibody Testing SWOT Analysis
 Table 76. Shenzhen Lvshiyuan Biotechnology Recent Developments
 Table 77. Phadia Corporation Information
 Table 78. Phadia Description and Major Businesses
 Table 79. Phadia Product Models, Descriptions and Specifications
 Table 80. Phadia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Phadia Sales Value Proportion by Product in 2024
 Table 82. Phadia Sales Value Proportion by Application in 2024
 Table 83. Phadia Sales Value Proportion by Geographic Area in 2024
 Table 84. Phadia Allergen IgG Antibody Testing SWOT Analysis
 Table 85. Phadia Recent Developments
 Table 86. Oumeng Corporation Information
 Table 87. Oumeng Description and Major Businesses
 Table 88. Oumeng Product Models, Descriptions and Specifications
 Table 89. Oumeng Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Oumeng Sales Value Proportion by Product in 2024
 Table 91. Oumeng Sales Value Proportion by Application in 2024
 Table 92. Oumeng Sales Value Proportion by Geographic Area in 2024
 Table 93. Oumeng Allergen IgG Antibody Testing SWOT Analysis
 Table 94. Oumeng Recent Developments
 Table 95. BioMerieux Corporation Information
 Table 96. BioMerieux Description and Major Businesses
 Table 97. BioMerieux Product Models, Descriptions and Specifications
 Table 98. BioMerieux Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. BioMerieux Recent Developments
 Table 100. Mediwiss Corporation Information
 Table 101. Mediwiss Description and Major Businesses
 Table 102. Mediwiss Product Models, Descriptions and Specifications
 Table 103. Mediwiss Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Mediwiss Recent Developments
 Table 105. Danaher Corporation Information
 Table 106. Danaher Description and Major Businesses
 Table 107. Danaher Product Models, Descriptions and Specifications
 Table 108. Danaher Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Danaher Recent Developments
 Table 110. Omega Diagnostics Group Corporation Information
 Table 111. Omega Diagnostics Group Description and Major Businesses
 Table 112. Omega Diagnostics Group Product Models, Descriptions and Specifications
 Table 113. Omega Diagnostics Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Omega Diagnostics Group Recent Developments
 Table 115. Biomerica Corporation Information
 Table 116. Biomerica Description and Major Businesses
 Table 117. Biomerica Product Models, Descriptions and Specifications
 Table 118. Biomerica Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Biomerica Recent Developments
 Table 120. Key Raw Materials Distribution
 Table 121. Raw Materials Key Suppliers
 Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 123. Milestones in Production Technology Evolution
 Table 124. Distributors List
 Table 125. Market Trends and Market Evolution
 Table 126. Market Drivers and Opportunities
 Table 127. Market Challenges, Risks, and Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources


List of Figures
 Figure 1. Allergen IgG Antibody Testing Product Picture
 Figure 2. Global Allergen IgG Antibody Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Reagents Product Picture
 Figure 4. Equipment Product Picture
 Figure 5. Global Allergen IgG Antibody Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Child
 Figure 7. Aldult
 Figure 8. Allergen IgG Antibody Testing Report Years Considered
 Figure 9. Global Allergen IgG Antibody Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Allergen IgG Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Allergen IgG Antibody Testing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Allergen IgG Antibody Testing Revenue Market Share by Region (2020-2031)
 Figure 13. Global Allergen IgG Antibody Testing Sales (2020-2031) & (K Units)
 Figure 14. Global Allergen IgG Antibody Testing Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 15. Global Allergen IgG Antibody Testing Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Allergen IgG Antibody Testing Sales Volume Market Share in 2024
 Figure 17. Global Allergen IgG Antibody Testing Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Reagents Revenue Market Share by Manufacturer in 2024
 Figure 20. Equipment Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Allergen IgG Antibody Testing Sales Market Share by Type (2020-2031)
 Figure 22. Global Allergen IgG Antibody Testing Revenue Market Share by Type (2020-2031)
 Figure 23. Global Allergen IgG Antibody Testing Sales Market Share by Application (2020-2031)
 Figure 24. Global Allergen IgG Antibody Testing Revenue Market Share by Application (2020-2031)
 Figure 25. North America Allergen IgG Antibody Testing Sales YoY (2020-2031) & (K Units)
 Figure 26. North America Allergen IgG Antibody Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Allergen IgG Antibody Testing Sales Revenue (US$ Million) in 2024
 Figure 28. North America Allergen IgG Antibody Testing Sales Volume (K Units) by Type (2020- 2031)
 Figure 29. North America Allergen IgG Antibody Testing Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Allergen IgG Antibody Testing Sales Volume (K Units) by Application (2020-2031)
 Figure 31. North America Allergen IgG Antibody Testing Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Allergen IgG Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Allergen IgG Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Allergen IgG Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Allergen IgG Antibody Testing Sales YoY (2020-2031) & (K Units)
 Figure 36. Europe Allergen IgG Antibody Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Allergen IgG Antibody Testing Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Allergen IgG Antibody Testing Sales Volume (K Units) by Type (2020-2031)
 Figure 39. Europe Allergen IgG Antibody Testing Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Allergen IgG Antibody Testing Sales Volume (K Units) by Application (2020-2031)
 Figure 41. Europe Allergen IgG Antibody Testing Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Allergen IgG Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 43. France Allergen IgG Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Allergen IgG Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Allergen IgG Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Allergen IgG Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Allergen IgG Antibody Testing Sales YoY (2020-2031) & (K Units)
 Figure 48. Asia-Pacific Allergen IgG Antibody Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Allergen IgG Antibody Testing Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Allergen IgG Antibody Testing Sales Volume (K Units) by Type (2020- 2031)
 Figure 51. Asia-Pacific Allergen IgG Antibody Testing Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Allergen IgG Antibody Testing Sales Volume (K Units) by Application (2020-2031)
 Figure 53. Asia-Pacific Allergen IgG Antibody Testing Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Allergen IgG Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Allergen IgG Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Allergen IgG Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Allergen IgG Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 58. India Allergen IgG Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Allergen IgG Antibody Testing Sales YoY (2020-2031) & (K Units)
 Figure 60. Central and South America Allergen IgG Antibody Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Allergen IgG Antibody Testing Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Allergen IgG Antibody Testing Sales Volume (K Units) by Type (2021-2031)
 Figure 63. Central and South America Allergen IgG Antibody Testing Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Allergen IgG Antibody Testing Sales Volume (K Units) by Application (2020-2031)
 Figure 65. Central and South America Allergen IgG Antibody Testing Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Allergen IgG Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Allergen IgG Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Allergen IgG Antibody Testing Sales YoY (2020-2031) & (K Units)
 Figure 69. Middle East and Africa Allergen IgG Antibody Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Allergen IgG Antibody Testing Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Allergen IgG Antibody Testing Sales Volume (K Units) by Type (2021-2031)
 Figure 72. South America Allergen IgG Antibody Testing Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Allergen IgG Antibody Testing Sales Volume (K Units) by Application (2020-2031)
 Figure 74. Middle East and Africa Allergen IgG Antibody Testing Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Allergen IgG Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Allergen IgG Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Allergen IgG Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Allergen IgG Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 79. Allergen IgG Antibody Testing Industry Chain Mapping
 Figure 80. Regional Allergen IgG Antibody Testing Manufacturing Base Distribution (%)
 Figure 81. Global Allergen IgG Antibody Testing Production Market Share by Region (2020-2031)
 Figure 82. Allergen IgG Antibody Testing Production Process
 Figure 83. Regional Allergen IgG Antibody Testing Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD